AFTPH and pancreatic adenocarcinoma: This analysis indicated that low expression of AFTPH was associated with favorable survival of BRCA, DLBC, LUSC, and PAAD, suggesting AFTPH might be an oncogenetic factor in BRCA, DLBC, LUSC, and PAAD.